← Browse by Condition
Medical Condition

brain neoplasm

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT02800486 Phase 2
Recruiting

Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA

Enrollment
37 pts
Location
United States
Sponsor
Northwell Health
View Trial →